Network origin in Andrew Abram first degree
Entity | Entity type | Industry | |
---|---|---|---|
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA.
5
| Holding Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Abram via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BECTON, DICKINSON AND COMPANY | Medical Specialties | Chief Tech/Sci/R&D Officer | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Human Resources Officer | |
Bear Stearns Asset Management, Inc.
Bear Stearns Asset Management, Inc. Investment ManagersFinance Bear Stearns Asset Management Inc (Bear Stearns) is a Private Equity/Venture Capital firm, a subsidiary of The Bear Stearns Cos LLC founded in 1985. The firm is headquartered in the US. | Investment Managers | Corporate Officer/Principal | |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
K2X TECHNOLOGY & LIFE SCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman Director/Board Member | |
Experimed Bioscience, Inc.
Experimed Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Experimed Bioscience, Inc. engages in research and development of drugs. The company was founded by Schepartz Alanna and is headquartered in South San Francisco, CA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
CANCER PREVENTION PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Respiratory Motion, Inc.
Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Medical Specialties | Director/Board Member | |
Achelios Therapeutics, Inc.
Achelios Therapeutics, Inc. BiotechnologyHealth Technology Achelios Therapeutics, Inc. operates as a bio-pharmaceutical development company. It specializes in non-steroidal anti-inflammatory drug. The company was founded by Crist J. Frangakis and is headquartered in Chaple Hill, NC. | Biotechnology | Director/Board Member | |
Institutional Venture Partners
Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Stanford University | College/University | Graduate Degree | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | General Counsel Corporate Officer/Principal | |
Caltech Surveys Ltd.
Caltech Surveys Ltd. Engineering & ConstructionIndustrial Services Caltech Surveys Ltd. provides mapping and data management services. Its services include well site surveys, digital surveys, digital mapping, utility surveys, construction surveys, underground facility location, and pipeline surveys. The company was founded on March 21, 1990 and is headquartered in Calgary, Canada. | Engineering & Construction | Corporate Officer/Principal | |
Yale University | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University of Basel | College/University | Doctorate Degree | |
Easton Capital Investment Group
Easton Capital Investment Group Investment ManagersFinance Easton Capital Investment Group (Easton) is a Venture Capital firm which is founded in 2000 by John H. Friedman. The firm is headquartered in New York ,US. | Investment Managers | Founder Corporate Officer/Principal | |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member Founder | |
The European Association for Bioindustries | Corporate Officer/Principal | ||
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
VistaGen, Inc. | Chairman | ||
VISTAGEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Director/Board Member | |
Shimojani LLC
Shimojani LLC BiotechnologyHealth Technology Shimojani LLC prevents hemorrhagic conversion in ischemic stroke patients. The company was founded by Larry M. Kauvar and is headquartered in San Francisco, CA. | Biotechnology | Founder | |
George Washington University Law School | College/University | Graduate Degree | |
New York University School of Law | College/University | Graduate Degree | |
Nuvox Pharma LLC
Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
Epalex Corp.
Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Chairman | |
Sciele Pharmaceuticals, Inc. | Director/Board Member | ||
Gore Range Capital LLC
Gore Range Capital LLC Investment ManagersFinance Gore Range Capital LLC (Gore Range Capital) is a venture capital firm founded in 2015 by Ethan Rigel. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Aether, Inc. | Director/Board Member | ||
NuvOx Therapeutics, Inc.
NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Vytacera Pharma, Inc. | Chairman |
Statistics
International
United States | 46 |
Switzerland | 4 |
Canada | 2 |
Belgium | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 3 |
Distribution Services | 2 |
Operational
Director/Board Member | 61 |
Corporate Officer/Principal | 13 |
Chairman | 10 |
President | 8 |
Founder | 7 |
Most connected contacts
Insiders | |
---|---|
Jon Saxe | 43 |
John H. Friedman | 26 |
Stefan Ryser | 16 |
Larry M. Kauvar | 10 |
Stote Ellsworth | 6 |
- Stock Market
- Insiders
- Andrew Abram
- Company connections